IHS Chemical Week

Regions :: Western Europe :: Switzerland

Lonza Signs Licensing and Supply Agreements with California Stem Cell

12:17 AM MDT | June 7, 2010 | Deepti Ramesh

Lonza says it has entered into worldwide, exclusive licensing and supply agreements with California Stem Cell (Irvine, CA), a privately held company that manufactures high-purity human cells for drug discovery, predictive toxicology and clinical application. The Lonza-California Stem Cell collaboration will make novel pluripotent stem cell products readily available to researchers worldwide. “This partnership will address the evolving needs of the research community by making broadly available high purity, human pluripotent stem cell-derived cells and...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa